Alliance for Regenerative Medicine

It’s a hot day on Capitol Hill, but that’s not stopping our members and advocates! Below are some highlights from today’s meetings with Congressional offices at our 2024 Cell & Gene Congressional Fly-In. #CGFlyIn24

Good morning from Capitol Hill! Our teams are preparing to meet with legislative offices today to champion policies that support life-saving cell and gene therapies for patients. Here’s a review of our three legislative asks: #1) Support the MVP Act (H.R. 2666/S. 4204) #2) Support the Accelerating Kids’ Access to Care Act (H.R. 4758/S. 2372) #3) Reauthorize the Rare Pediatric Disease Priority Review Voucher Program #CGFlyIn24

That wraps up Day 1 of our 2024 Cell & Gene Congressional Fly-In. Today, we heard from leading experts and government officials about how the United States can modernize our healthcare system to deliver cell and gene therapies to patients. Our teams are now huddling in preparation for tomorrow where we will spend the day meeting with lawmakers on Capitol Hill. Thank you to everyone who made Day 1 a smashing success! #CGFlyIn24

Good afternoon from the nation’s capital! ARM is kicking off Day 1 of our 2024 Cell and Gene Congressional Fly-In, where we will hear from leading government figures and experts on the policy topics impacting patient access to cell and gene therapies. Below is today’s lineup. 1:30pm – 2:00pm | Keynote Speaker Stephanie Heathman, M.S., Opie Jones Foundation 2:00pm – 2:30pm | Keynote Speaker Dr. Nicole Verdun, Director, Office of Therapeutic Products, FDA 2:30pm – 3:00pm | Stakeholder Panel Aisling McDonough, Chief of Staff, Representative Anna Eshoo (D-CA-16), Ranking Member of the House Energy and Commerce Health Subcommittee Blake Thelander, Health Policy Advisory, Representative Miller-Meeks (R-IA-01) 3:10pm – 4:10pm | Election Outlook Panel Former United States Congressmen Jim Davis, Ron Klein, Tom Reynolds, and Tom Davis #CGFlyIn24

Only three short days away from ARM’s 2024 Cell and Gene Congressional Fly-In! Here is our third and final ask to Congress. Ask #3 - Tell Congress to reauthorize the Rare Pediatric Disease Priority Review Voucher Program Why? Support innovation and fast access to treatments for children with rare diseases. #CGFlyIn24

Congrats to our 20 GROW interns who have hit the ground running in their summer internships with our member organizations. 🎉 They are taking on projects ranging from business development to biomedical engineering and building their skills to become future leaders within the sector. Later this summer, we'll showcase some of their individual efforts and accomplishments. ARM's GROW RegenMed Internship Program provides crucial, early-career paid opportunities in the regenerative medicine sector for Black undergraduate and graduate students. Learn more about the program here: https://lnkd.in/g-D3p3c

We’re only four days away from ARM’s 2024 Congressional Cell & Gene Fly-In to advocate for patient access to cell and gene therapies. Here’s our second ask to Congress. Ask #2 – Support the Accelerating Kids’ Access to Care Act (H.R. 4758/S. 2372) Why? It can alleviate burdens for children who need to travel across state lines to receive cell and gene therapies. #CGFlyIn24

Are you passionate about advancing the field of cell and gene therapy? The Alliance for Regenerative Medicine is looking to grow our network! Have your company join the world’s top network of leaders in cell and gene therapy. Here’s a snapshot of the benefits of joining ARM: ➡️ Exclusive networking events with industry leaders ➡️ Help shape the sector’s policy and regulatory environment ➡️ Discounted rates for first-in-class conferences Join ARM today and be part of the future of healthcare. To learn more, contact member@alliancerm.org.

ARM’s 2024 Cell & Gene Congressional Fly-In will start Monday! We're gathering our members and stakeholders to champion cell and gene therapies on Capitol Hill. Leading up to July 15, we’ll review our three key asks to Congress that will improve patient access to this transformative medicine. Ask 1 - Support the MVP Act (H.R. 2666) Why? Value-based payment arrangements are crucial for expanding patient access to cell and gene therapies. #CGFlyIn24

ARM's Cell & Gene Meeting on the Mesa is the place to be for industry leaders. But don't take it from us. Hear what our attendees have to say! 📽️ Experience the cell and gene therapy sector's foremost annual conference. Join us October 7-9 for the next Meeting on the Mesa at its new home in Phoenix, AZ. Register ➡️ www.meetingonthemesa.com Sponsor ➡️ https://lnkd.in/euPJKGvX